Nalbuphine Coupons & Discount Card - Compare Prices Near You
My prescription
Edit
1ML of 10MG/ML, Nalbuphine (1 Ampule)
Select pharmacy
CVS
$25.92
COUPON PRICE
Walmart
$1.01
COUPON PRICE
Walgreens
$2.00
COUPON PRICE
Rite Aid
$4.30
COUPON PRICE
Albertsons
$10.84
COUPON PRICENalbuphine savings card
Show this card to your pharmacistCVS
$25.92
BIN
ID
PCN
GRP
019876
LH4D234357
CHIPPO
LHX
Powered by
Related opioid agonist/antagonists prescriptions
More prescriptions for pain
Related opioid agonist/antagonists prescriptions
More prescriptions for pain
Nalbuphine dosage forms
| Dosage | Quantity | Price from | Per unit |
|---|---|---|---|
| 1ML of 10MG/ML | 1 Ampule | $1.01 | $1.01 |
| 1ML of 20MG/ML | 1 Ampule | $2 | $2 |
Nalbuphine Warnings
The following provides essential safety information regarding the use of nalbuphine. Please review these details carefully and consult your healthcare provider if you have any questions or concerns.
Respiratory Depression: Nalbuphine may cause life-threatening breathing difficulties, especially if taken with other medications that depress breathing (such as benzodiazepines, opioids, muscle relaxants, or sleep aids) or with alcohol. Inform your healthcare provider of all medications you are taking. Increased risk factors include a history of substance abuse, alcohol consumption, respiratory conditions like asthma, older age (65+), low body weight, and general frailty.
Adrenal Insufficiency: Long-term use of opioids like nalbuphine can lead to low adrenal hormone levels, presenting symptoms such as weakness, fatigue, dizziness, nausea, vomiting, and loss of appetite. Notify your healthcare provider immediately if you experience these symptoms, especially if nalbuphine is used for more than a month.
Hypotension: Nalbuphine can cause extremely low blood pressure, especially when combined with medications that depress the central nervous system, such as general anesthetics and sedatives. Your healthcare provider will monitor your blood pressure during treatment. Report any feelings of lightheadedness, dizziness, fatigue, or fainting to your provider.
Increased Intracranial Pressure: Due to its effect on lowering breathing rate, nalbuphine may increase pressure in the brain, posing risks for individuals with brain tumors, head injuries, or pre-existing high intracranial pressure. Your healthcare provider will frequently monitor your breathing and consciousness levels during treatment.
Gastrointestinal Risks: Nalbuphine can exacerbate stomach or digestive issues, increasing the risk of pancreatitis. It should not be used by individuals with intestinal blockages. Discuss any history of stomach problems with your provider, and consult them if you experience constipation while on nalbuphine.
Seizure Risk: Nalbuphine may increase the likelihood of seizures in individuals with a personal or medical history of seizures. Ensure your healthcare provider is aware of your medical history for closer monitoring if necessary.
Serotonin Syndrome: Concurrent use of nalbuphine with serotonergic medications (e.g., fluoxetine, duloxetine, MAOIs, trazodone) may lead to a potentially fatal condition called serotonin syndrome. Inform your healthcare provider about all your current medications. Seek immediate medical attention and discontinue nalbuphine if you experience symptoms like diarrhea, high fever, distress, confusion, tremors, sweating, rapid heartbeat, or muscle stiffness.
Impaired Alertness: Nalbuphine can impair alertness, causing drowsiness and reduced concentration. Your provider will assess when it is safe for you to drive or engage in tasks that require full attention.
Please ensure you discuss these risks with your healthcare provider to tailor the safest treatment plan for your needs.
Is nalbuphine a strong or weak opioid?
Nalbuphine is considered a mixed agonist-antagonist opioid. It is generally classified as a moderate-strength opioid, providing analgesic effects that are less potent than strong opioids like morphine but stronger than weak opioids such as codeine.
Is tramadol the same as nalbuphine?
Tramadol and nalbuphine are not the same. Tramadol is an opioid analgesic used to treat moderate to moderately severe pain, while nalbuphine is a mixed opioid agonist-antagonist used for pain relief and sometimes as an adjunct to anesthesia. They have different mechanisms of action and are used in different clinical scenarios.
Is NUBAIN still used?
Yes, Nubain (nalbuphine) is still used in medical practice. It is an opioid analgesic used for the management of moderate to severe pain and is sometimes used as an adjunct to anesthesia. However, its use may vary based on regional medical guidelines and availability.
Why is there a NUBAIN shortage?
There is a shortage of Nubain due to manufacturing delays and increased demand. Pharmaceutical companies may face challenges in production, such as supply chain disruptions or regulatory issues, which can contribute to the shortage. Additionally, fluctuations in demand for certain medications can also impact availability. It is advisable to consult with healthcare providers for alternative treatments or updates on the availability of Nubain.
How strong is nalbuphine compared to morphine?
Nalbuphine is considered to be approximately equal in analgesic potency to morphine. However, nalbuphine has a ceiling effect for respiratory depression, which means that increasing the dose beyond a certain point does not increase the risk of respiratory depression, unlike morphine. This makes nalbuphine a safer option in certain situations.